Meanwhile, missense mutations accounted for 7.7% (2/26) of MAP2K1 mutations in AIS, 5.9% (2/34) in MIA, and 81.8% (18/22) in IAC (Fig. 3A, Fig. S6A, Table S2). This evidence concerns the gene MAP2K1 and androgen insensitivity syndrome.